WGS•benzinga•
GeneDx Preliminary FY24 Revenue To Exceed $299M With Q4 Revenue At Least $92M; FY Adjusted Gross Margin Projected At 64% And Q4 At 68%
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 13, 2025 by benzinga